Sheila Gujrathi - Jun 8, 2023 Form 4 Insider Report for Ventyx Biosciences, Inc. (VTYX)

Role: Director
Signature: /s/ Christopher Krueger, as Attorney-in-Fact
Stock symbol: VTYX
Transactions as of: Jun 8, 2023
Transactions value $: $0
Form type: 4
Date filed: 6/12/2023, 04:48 PM
Previous filing: Mar 31, 2023
Next filing: Jun 16, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VTYX	Stock Option (right to buy)	Award	$0	+15.9K		$0.00	15.9K	Jun 8, 2023	Common Stock	15.9K	$34.83	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to the option shall vest on the earlier of (i) the one-year anniversary of the date of grant or, (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date the option was granted, in each case, subject to the reporting person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through the applicable vesting date.

Content

The shares subject to the option shall vest on the earlier of (i) the one-year anniversary of the date of grant or, (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date the option was granted, in each case, subject to the reporting person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through the applicable vesting date.